caseins has been researched along with ak 295 in 1 studies
| Studies (caseins) | Trials (caseins) | Recent Studies (post-2010) (caseins) | Studies (ak 295) | Trials (ak 295) | Recent Studies (post-2010) (ak 295) |
|---|---|---|---|---|---|
| 16,863 | 561 | 4,170 | 13 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banik, NL; Bartus, R; Hogan, EL; James, T; Matzelle, D | 1 |
1 other study(ies) available for caseins and ak 295
| Article | Year |
|---|---|
New inhibitors of calpain prevent degradation of cytoskeletal and myelin proteins in spinal cord in vitro.
Topics: Animals; Calpain; Caseins; Cysteine Proteinase Inhibitors; Cytoskeletal Proteins; Dipeptides; Enzyme Inhibitors; Half-Life; Myelin Proteins; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Spinal Cord | 1998 |